Matthew Yurgelun

29PUBLICATIONS
239CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 27, 2026
Beyond the Locus: Learning Tumor Microsatellite Instability Status From Genome and Transcriptome Sequencing.

|Jul 08, 2026
Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

|Apr 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.

|Feb 13, 2026
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun

|Oct 11, 2025
Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Asaf Maoz, Leah Biller, Marios Giannakis

|Sep 02, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.

Rishi Surana, Micaela Morgado, Ashwin Somasundaram

Pageof 5

Frequent Collaborators

9 joint publications

Sapna Syngal

8 joint publications

Chinedu Ukaegbu

8 joint publications

Brian M Wolpin

8 joint publications

Jonathan O Nowak